Corporates
2023
Spark-Techspark-tech: Pioneering the Future of Medical and Biological ResearchEstablished in 2015 and based in Krakow, Poland, SPARK-TECH is dedicated to transforming medical and biological research through innovative, autonomous, user-friendly, and secure laboratory equipment, leveraging artificial intelligence, robotics, and information engineering.
In 2023, we introduced a groundbreaking microbiome diagnostic service utilizing third-generation sequencing. Our service features one of the largest and most comprehensive research panels globally, developed with our proprietary molecular probes and bioinformatics algorithms. This unique offering is available exclusively through SPARK-TECH. We provide diagnostic services for patients, veterinary practices, industry, academia, and R&D, aiming to reduce antibiotic usage and enhance treatment strategies for a healthier future.
One of our notable inventions, the Spark-Tech Biobanking System (STBS), automates the separation, preservation, and biobanking of human Peripheral Blood Mononuclear Cells (PBMCs). This innovation has received significant recognition and funding, including support from the European Commission's Instrument SME program and national funding bodies like NCBR and PARP.
We are actively seeking partners for the distribution of our microbiome sequencing service and clients from the industry.
In 2023, we introduced a groundbreaking microbiome diagnostic service utilizing third-generation sequencing. Our service features one of the largest and most comprehensive research panels globally, developed with our proprietary molecular probes and bioinformatics algorithms. This unique offering is available exclusively through SPARK-TECH. We provide diagnostic services for patients, veterinary practices, industry, academia, and R&D, aiming to reduce antibiotic usage and enhance treatment strategies for a healthier future.
One of our notable inventions, the Spark-Tech Biobanking System (STBS), automates the separation, preservation, and biobanking of human Peripheral Blood Mononuclear Cells (PBMCs). This innovation has received significant recognition and funding, including support from the European Commission's Instrument SME program and national funding bodies like NCBR and PARP.
We are actively seeking partners for the distribution of our microbiome sequencing service and clients from the industry.
Address
Rynek Główny 28, 31-010 Kraków, Poland
Commercial Register
sp. z o.o.
6772391908
Life Science Landscape
Bio-Tech
Med-Tech
Agri/Food-Tech